Ferrostatin-1, a ferroptosis inhibitor, mitigates all-trans-retinal-induced retinal pigment epithelium degeneration in mice

作者：Xiao‐Qing Shen, Yuling Chen, Baoting He, Ruitong Xi, Jingmeng Chen, Yalin Wu · 发表于：Journal of Translational Medicine · 年份：2025 · DOI：10.1186/s12967-025-07195-7 · 被引用次数：9 · 研究领域：Ferroptosis and cancer prognosis、Retinal Diseases and Treatments、Retinoids in leukemia and cellular processes

Disruption of the retinoid (visual) cycle causes all- trans -retinal (atRAL) to accumulate in photoreceptors and retinal pigment epithelium (RPE), contributing to Stargardt disease type 1 (STGD1) and dry age-related macular degeneration (dAMD). Yet, the mechanisms underlying atRAL-induced RPE degeneration are not well understood. Here, we explored whether ferroptosis, a form of regulated cell death marked by iron-dependent lipid peroxidation, mediated RPE damage by atRAL. Cell and animal models of STGD1 and dAMD were established using ARPE-19 cells loaded with atRAL and Abca4 −/− Rdh8 −/− mice subjected to light exposure. Cell viability and morphology, mitochondrial morphology, ferrous iron (Fe 2+ ) levels, reactive oxygen species (ROS) production, lipid peroxidation, and ferroptosis-related gene and protein expression were assessed using MTS assay, inverted and confocal microscopy, fluorescence staining, quantitative real-time polymerase chain reaction (qRT-PCR), and Western blotting, respectively. The conditions of mouse retina were evaluated by electroretinography (ERG), optical coherence tomography (OCT), fundus imaging, and immunofluorescence labeling. atRAL triggered ferroptosis of ARPE-19 cells through Fe 2+ accumulation, ROS generation, lipid peroxidation, mitochondrial damage, and abnormal expression of typical ferroptosis-related genes and proteins. These effects were capable of being alleviated by treatment with ferrostatin-1 (Fer-1), a potent ferroptosis inhibitor...